Joop Gäken

发表

A functional assay for microRNA target identification and validation

G. Mufti, F. Farzaneh, C. Chronis, 2010, Nucleic acids research.

TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis

G. Mufti, N. Lea, B. Czepulkowski, 2013, British journal of haematology.

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

G. Mufti, N. Heaton, N. Lea, 2005, Gastroenterology.

G. Mufti, A. Mohamedali, Alexander Smith, 2013 .

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.

G. Mufti, N. Lea, U. Germing, 2007, Blood.

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.

G. Mufti, J. Maciejewski, N. Lea, 2010, Blood.

BRK1: BRICK1, SCAR/WAVE Actin-Nucleating Complex Subunit F-actin: filamentous actin miRNA: microRNA shRNA: short hairpin RNA TCR: T cell receptor WAVE: Wiskott-Aldrich Syndrome Protein (WASP) Family Verprolin-Homologous Protein

G. Mufti, D. Darling, A. Ramsay, 2018 .